NCT06722625 Telemedical Algorithm-Supported Care for Hypertension
| NCT ID | NCT06722625 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Poznan University of Medical Sciences |
| Condition | Arterial Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-10-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2023-10-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Hypertension is a major global health issue, affecting around 9 million people in Poland. While some studies indicate that telemonitoring benefits patients with hypertension, there is a lack of research evaluating tools that assist doctors in managing these patients. The objective of this study is to assess a blood pressure monitoring system with an integrated algorithm that aids doctors in the decision-making process.
Eligibility Criteria
Inclusion Criteria: 1. Voluntarily signing an informed consent to participate in the study. 2. Age between 18 and 80 years. 3. Diagnosis of hypertension according to the Polish Society of Hypertension criteria from 2019, either already treated or newly diagnosed. 4. Blood pressure exceeding 140/90 mmHg in office measurements (during the screening visit). Exclusion Criteria: 1. Suspicion or diagnosis of secondary hypertension. 2. Pregnant women, breastfeeding women, or those planning pregnancy during the study period.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06722625 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Arterial Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06722625 currently recruiting?
Yes, NCT06722625 is actively recruiting participants. Contact the research team at puruski@ump.edu.pl for enrollment information.
Where is the NCT06722625 trial being conducted?
This trial is being conducted at Poznan, Poland.
Who is sponsoring the NCT06722625 clinical trial?
NCT06722625 is sponsored by Poznan University of Medical Sciences. The trial plans to enroll 200 participants.